Monografie
A patient-specific CT-Mesh hybrid computational phantom and its applications in out-of-field dose, equivalent dose, and secondary cancer risk estimation in proton therapy
- Sprache
-
Englisch
- Identifier
-
1255226161
Thema
Risk; Cancer; Therapeutics
Beteiligte Personen und Organisationen
Kollitz, Erika
Parodi, Katia
Parodi, Katia
- DOI
-
10.5282/edoc.29634
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
03.06.2022, 09:17 MESZ
Objekttyp
- Monografie
Beteiligte
- Kollitz, Erika
- Parodi, Katia
Ähnliche Objekte (12)
Low-dose imaging for particle therapy with fluence-modulated proton computed tomography
Range uncertainty reductions in proton therapy and associated benefits for patients with brain or skull base tumors
Development and validation of two novel x-ray filters in computed tomography with focus on fluence modulation for region-of-interest imaging
Experimental and computational investigation of water-to-air stopping power ratio for ion chamber dosimetry in carbon ion radiotherapy
Quantification and management of uncertainties in radiation therapy
Optimization strategies for respiratory motion management in stereotactic body radiation therapy
Nanotools for cancer research and therapy
Scatter correction of 4D cone beam computed tomography images for respiratory phase-dependent proton dose calculation
Towards EPID-based 3D in vivo dosimetry for modern radiation therapy
EPID-based 3D dosimetry for pre-treatment IMRT/VMAT quality assurance
Characterization of bispecific antibodies that drive synthetic agonistic receptor-transduced T cells to mediate specific and conditional therapy in human pancreatic cancer models
Investigations of radiation shielding, diagnostic methods and imaging for conventional and laser-driven radiation sources
Low-dose imaging for particle therapy with fluence-modulated proton computed tomography
Range uncertainty reductions in proton therapy and associated benefits for patients with brain or skull base tumors
Development and validation of two novel x-ray filters in computed tomography with focus on fluence modulation for region-of-interest imaging
Experimental and computational investigation of water-to-air stopping power ratio for ion chamber dosimetry in carbon ion radiotherapy
Quantification and management of uncertainties in radiation therapy
Optimization strategies for respiratory motion management in stereotactic body radiation therapy
Nanotools for cancer research and therapy
Scatter correction of 4D cone beam computed tomography images for respiratory phase-dependent proton dose calculation
Towards EPID-based 3D in vivo dosimetry for modern radiation therapy
EPID-based 3D dosimetry for pre-treatment IMRT/VMAT quality assurance
Characterization of bispecific antibodies that drive synthetic agonistic receptor-transduced T cells to mediate specific and conditional therapy in human pancreatic cancer models
Investigations of radiation shielding, diagnostic methods and imaging for conventional and laser-driven radiation sources
Low-dose imaging for particle therapy with fluence-modulated proton computed tomography
Range uncertainty reductions in proton therapy and associated benefits for patients with brain or skull base tumors
Development and validation of two novel x-ray filters in computed tomography with focus on fluence modulation for region-of-interest imaging
Experimental and computational investigation of water-to-air stopping power ratio for ion chamber dosimetry in carbon ion radiotherapy
Quantification and management of uncertainties in radiation therapy
Optimization strategies for respiratory motion management in stereotactic body radiation therapy
Nanotools for cancer research and therapy
Scatter correction of 4D cone beam computed tomography images for respiratory phase-dependent proton dose calculation
Towards EPID-based 3D in vivo dosimetry for modern radiation therapy
EPID-based 3D dosimetry for pre-treatment IMRT/VMAT quality assurance
Characterization of bispecific antibodies that drive synthetic agonistic receptor-transduced T cells to mediate specific and conditional therapy in human pancreatic cancer models